Portal:CPTAC/Hallmark/Deregulating
From WikiPathways
(Difference between revisions)
| Line 5: | Line 5: | ||
*[[Pathway:WP4206]] Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway | *[[Pathway:WP4206]] Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway | ||
*[[Pathway:WP4290]] Metabolic reprogramming in colon cancer | *[[Pathway:WP4290]] Metabolic reprogramming in colon cancer | ||
| + | *[[Pathway:WP4241]] Type 2 papillary renal cell carcinoma | ||
Revision as of 00:46, 28 September 2018
- Pathway:WP2868 TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer
- Pathway:WP1471 Target Of Rapamycin (TOR) Signaling
- Pathway:WP534 Glycolysis and Gluconeogenesis
- Pathway:WP143 Fatty Acid Beta Oxidation
- Pathway:WP4206 Hereditary Leiomyomatosis and Renal Cell Carcinoma Pathway
- Pathway:WP4290 Metabolic reprogramming in colon cancer
- Pathway:WP4241 Type 2 papillary renal cell carcinoma
